tradingkey.logo
tradingkey.logo
検索

CeriBell Inc

CBLL
ウォッチリストに追加
23.820USD
+0.200+0.85%
終値 09-23 16:00(ET)
903.73M時価総額
損失額直近12ヶ月PER

CeriBell Incについて 企業名

CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.

CeriBell Inc プロフィール

企業コードCBLL
会社名Ceribell Inc
上場日Oct 11, 2024
最高経営責任者「CEO」Chao (Xingjuan)
従業員数281
証券種類Ordinary Share
決算期末Oct 11
本社所在地360 N. Pastoria Avenue
都市SUNNYVALE
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号94085
電話番号18004360826
ウェブサイトhttps://ceribell.com/
企業コードCBLL
上場日Oct 11, 2024
最高経営責任者「CEO」Chao (Xingjuan)

CeriBell Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.01M
+0.39%
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.01M
+0.39%
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.01M
+0.39%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
955.76K
-3.70%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
955.76K
-3.70%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
955.76K
-3.70%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
150.11K
+5.59%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
150.11K
+5.59%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
150.11K
+5.59%
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
94.33K
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.01M
+0.39%
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.01M
+0.39%
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.01M
+0.39%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
955.76K
-3.70%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
955.76K
-3.70%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
955.76K
-3.70%

よくある質問

CeriBell Incの上位5名の株主は誰ですか?

CeriBell Incの上位5名の株主は以下のとおりです。Dr. Josef Parvizi, M.D., Ph.D.

CeriBell Inc(CBLL)の株式を保有している機関の数はいくつですか?

2026Q1時点で、CeriBell Incの株式を保有している機関は236社あり、保有株式の総市場価値は約31.90Mで、全体の84.99%を占めています。2025Q4と比較して、機関の持ち株は-1637325.00増加しています。

CeriBell Incの最大の収益源は何ですか?

2026Q1において、EEG recorders and EEG headbands, point in time部門がCeriBell Incにとって最大の収益を生み出しており、その金額は21.24Mで、全収益の75.60%を占めています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。